Variant report
Variant | esv3427885 |
---|---|
Chromosome Location | chr7:124267966-124270239 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35936075 | chr7:124268026-124268027 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs576825904 | chr7:124268040-124268041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566678134 | chr7:124268043-124268044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78093751 | chr7:124268047-124268048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569709699 | chr7:124268050-124268051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1917357 | chr7:124268066-124268067 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs558627219 | chr7:124268086-124268087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544900765 | chr7:124268151-124268152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142547798 | chr7:124268160-124268161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147167020 | chr7:124268170-124268171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546934738 | chr7:124268181-124268182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544321061 | chr7:124268184-124268185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554633044 | chr7:124268210-124268211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs140253270 | chr7:124268220-124268221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532608449 | chr7:124268225-124268226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552099844 | chr7:124268243-124268244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6976457 | chr7:124268265-124268266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372078064 | chr7:124268267-124268268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537777941 | chr7:124268285-124268286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554441522 | chr7:124268302-124268303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192789446 | chr7:124268329-124268330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536264582 | chr7:124268351-124268352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs144242595 | chr7:124268382-124268383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115651622 | chr7:124268466-124268467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576879707 | chr7:124268467-124268468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114155727 | chr7:124268489-124268490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540943610 | chr7:124268505-124268506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183605158 | chr7:124268518-124268519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73221428 | chr7:124268550-124268551 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs544959869 | chr7:124268633-124268634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561574978 | chr7:124268636-124268637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79129819 | chr7:124268659-124268660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540292666 | chr7:124268661-124268662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544859509 | chr7:124268683-124268684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs370591554 | chr7:124268694-124268695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201386547 | chr7:124268708-124268709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs200118541 | chr7:124268709-124268710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs6962917 | chr7:124268711-124268712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79676348 | chr7:124268723-124268724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201781013 | chr7:124268725-124268726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs6943004 | chr7:124268730-124268731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs200789495 | chr7:124268731-124268732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200854385 | chr7:124268732-124268733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552620024 | chr7:124268747-124268748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147848656 | chr7:124268760-124268761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs531394008 | chr7:124268761-124268762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs141466343 | chr7:124268763-124268764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568035366 | chr7:124268766-124268767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534058439 | chr7:124268776-124268777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs547110824 | chr7:124268780-124268781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Epilepsy | 21635232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:124267800-124268600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr7:124268600-124270000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr7:124270000-124271400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |